NCAM1 and rheumatoid arthritis: Considering that the CD14bright/CD56+ monocyte subset only minimally overlaps the CD14bright/CD16+ monocyte subset, RA patients have a major shift toward pathological monocyte subpopulations at the expense of classical monocytes.